Genelux Corporation
Clinical trials sponsored by Genelux Corporation, explained in plain language.
-
Cancer-Killing virus shows promise in tough ovarian cancer trial
Disease control Recruiting nowThis Phase 3 study tests whether a modified virus called Olvi-Vec, given with chemotherapy and bevacizumab, can help women with ovarian cancer that no longer responds to platinum drugs. About 186 participants will receive either the virus combination or standard chemotherapy. The…
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Cancer-Fighting virus plus chemo and immunotherapy takes on lung cancer in new trial
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease got worse after initial treatment. It combines an injected virus (Olvi-Vec) that targets cancer cells, followed by chemotherapy and an immunotherapy drug, and compares it to standard chemotherapy a…
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC